- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 90,880 | 26.06.24 17:24:01 | -2,170 | -2,33% | 90,190 | 90,310 | 93,000 | 90,880 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 1.006,500 | 26.06.24 19:05:51 | +20,500 | +2,08% | 995,400 | 1.001,500 | 997,200 | 1.006,500 |
